NCT04721132 2026-03-05Atezolizumab and Bevacizumab Before Surgery for the Treatment of Resectable Liver CancerM.D. Anderson Cancer CenterPhase 2 Active not recruiting16 enrolled
NCT03942328 2026-02-24Modified Immune Cells (Autologous Dendritic Cells) and a Vaccine (Prevnar) Combined With Immune Checkpoint Inhibition After High-Dose External Beam Radiation Therapy in Treating Patients With Unresectable Liver CancerMayo ClinicPhase 1/2 Recruiting85 enrolled